ReviewImmunotherapy2016
Checkpoint inhibitors for renal cell carcinoma: current landscape and future directions.
Matthew Zibelman et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ReviewImmunotherapy2016
Matthew Zibelman et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.